Written Authority Required Drugs

Growth Hormone Program - paediatric patients

The Growth Hormone Program provides subsidised PBS treatment to eligible paediatric patients under a number of categories.

You can now get PBS authority approvals for the Growth Hormone Program online and in real time. Find out how you can join the other clinicians that are now using the Online PBS Authorities system.

About the program

The PBS subsidised section 100 Growth Hormone Program provides treatment to eligible children of short stature: helping them to achieve a final height within the normal population range.

Find out which medicines are available under the Growth Hormone Program on the PBS website.

Medical practitioners

Patients need an approved authority prescription to get treatment under the Growth Hormone Program.

To complete your authority prescription, use the PBS Growth Hormone Program Paediatric dose and cartridge quantity calculator on the PBS website. You can calculate the correct quantity and weekly dose for your patient.

You can submit either an online or written Growth Hormone authority application.

Online applications

From 1 February 2019, we’re updating the Online PBS Authorities system with updated policy and restrictions. During the update, certain Growth Hormone authority applications won’t be available in the Online PBS Authorities system.

Prescribers can submit PBS Growth Hormone applications through the Online PBS Authorities system for:

  • all initial patient, continuing as a reclassified patient and recommencement as a reclassified patient applications for these conditions:
    • risk of hypoglycaemia secondary to growth hormone deficiency in neonates/infants (N)
    • biochemical growth hormone deficiency and precocious puberty (PP)
    • short stature associated with Turner syndrome (TS)
    • short stature and poor body composition due to Prader-Willi syndrome (PW)
  • continuing treatment applications for all conditions
  • recommencement treatment applications for all conditions.

Submit online applications in the Online PBS Authorities system, you can access through:

Use the system to:

  • get an authority assessment in real time
  • reduce the waiting period for approved authority prescriptions
  • avoid postal delays and related costs
  • submit authority applications 24/7
  • cancel or amend an approved application not already dispensed
  • ask about your previous authority requests for a period of up to 2 years.

Use your Provider Digital Access (PRODA) account to access the Online PBS Authorities system. PRODA provides secure access to online government services. If you don’t have an account yet, register now.

To meet the PBS Growth Hormone restriction eligibility criteria you need to answer some questions and provide patient data in the Online PBS Authorities system.

If your authority is approved, you’ll see a PBS Authority Approval Number. Write this number and the PBS Item code on the prescription.

If your authority is rejected, you’ll see PBS reason codes explaining why your patient didn’t meet the eligibility criteria. You can amend your application and resubmit for assessment.

You can cancel an approved Growth Hormone authority prescription if it hasn’t been dispensed from an approved supplier.

You must contact us on the Complex Drugs enquiry line to get an approved authority prescription reissued.

Watch the video for a demonstration of how to request a Growth Hormone online authority.

Watch the video for a demonstration of how to edit a rejected Growth Hormone online authority.

Written applications

From 1 February 2019, certain Growth Hormone authority applications won’t be available in the Online PBS Authorities system. You’ll need to submit a written authority application form for assessment.

Submit a written authority application for initial patient, continuing as a reclassified patient and recommencement as a reclassified patient authority applications, for the conditions:

  • short stature and slow growth (SSSG)
  • short stature associated biochemical growth hormone deficiency (BGHD)
  • growth retardation secondary to an intracranial lesion, or cranial irradiation (CL/CI)
  • hypothalamic-pituitary disease secondary to a structural lesion, with hypothalamic obesity driven growth (HO)
  • short stature due to short stature homeobox gene disorders (SHOX)
  • short stature associated with chronic renal insufficiency (CR).

Submit written applications through either:

In form upload in HPOS you can:

  • send secure messages with your completed form and supporting information to us
  • avoid postal delays and related costs
  • create a return message with an approval number through the secure Mail Centre.

HPOS applications

Before the prescription goes to the patient or their carer for dispensing you must provide the:

  • PBS Authority Approval Number
  • PBS Item code.

Post applications

When you submit the completed prescription form and supporting information to us, you must tell us if we should return the approved prescription to you or your patient.

We’ll send the prescription to you or your patient with:

  • an approved by DHS stamp
  • the PBS Item code.

We’ll let you know in writing if we reject a written authority application submitted through HPOS or the post. We’ll do this through the channel you submitted the application.

There are no changes to existing arrangements for phone and written Repatriation Pharmaceutical Benefits Scheme (RPBS) approvals through the Veterans’ Affairs Pharmaceutical Approval Centre (VAPAC).

Initial treatment

For patients who need initial treatment, you need to complete and submit for approval:

Continuing treatment

To continue the patient’s treatment, you need to complete and submit for approval one of the following:

and:

  • any relevant supporting information
  • a valid Authority prescription.

Online PBS Authorities System availability for applications

The following table outlines if you can submit either online or written applications for paediatric patients for the different conditions and treatment phases.

Condition Treatment phase
  Initial
treatment
Continuing
treatment
Continuing
treatment as a
reclassified
patient
Recommencement
treatment
Recommencement
treatment as a
reclassified
patient
short stature and slow growth (SSSG) No Yes No Yes No
short stature associated with biochemical
growth hormone deficiency (BGHD)
No Yes No Yes No
growth retardation secondary to an intracranial
lesion, or cranial irradiation (CL/CI)
No Yes No Yes No
hypothalamic-pituitary disease secondary to a structural
lesion, with hypothalamic obesity driven growth (HO)
No Yes No Yes No
risk of hypoglycaemia secondary to growth
hormone deficiency in neonates/infants (N)
Yes Yes Yes Yes Yes
biochemical growth hormone deficiency and
precocious puberty (PP)
Yes Yes Yes Yes Yes
short stature associated with Turner syndrome (TS) Yes Yes Yes Yes Yes
short stature due to short stature homeobox
gene disorders (SHOX)
No Yes No Yes No
short stature associated with chronic renal
insufficiency (CR)
No Yes No Yes No
short stature and poor body composition
due to Prader-Willi syndrome (PW)
Yes Yes Yes Yes Yes

Approved suppliers

PBS subsidised Growth Hormone medicines can be dispensed at either an approved:

  • community pharmacy
  • participating PBS reform public hospital pharmacy
  • private hospital pharmacy.

Growth Hormone medicines are available through pharmaceutical wholesalers or from the manufacturer.

Under the Growth Hormone Program, you must supply the same brand for the original prescription and the repeat prescription.

Reimbursement for dispensing these medicines is the same as the process used for supplying PBS subsidised items listed under the Highly Specialised Drugs (HSD) Program. Calculate reimbursement using ex-manufacturer pricing, not ex-wholesaler pricing.

More information

You can contact us for more information on the Complex Drugs enquiry line.

Page last updated: 22 February 2019